Silo Pharma Inc. (NASDAQ: SILO) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT SILO PHARMA INC.

Silo Pharma Inc. (NASDAQ: SILO)
Listen to this Section


$6.00
-0.1350 ( -2.20% ) 34.2K

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

Market Data


Open $6.00
Previous Close $6.13
Volume 34.2K
Market Cap $6.65M
Day Range $5.60 - $6.41
52 Week Range $3.32 - $15.15
Shares Outstanding 1.08M
Change % -2.20%
Net Change ▼ -0.1350
Insider Ownership 0.00%
Exchange NASDAQ
SectorConsumer Discretionary
IndustryApparel
IPO Year2012
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: 27,420.00

Date Type Amount Purchased Purchaser
2025-05-28 Buy 10000.00 Weisblum Eric
2024-12-16 Buy 2500.00 Weisblum Eric
2024-11-22 Buy 2500.00 Weisblum Eric
2024-06-13 Buy 562.00 Weisblum Eric
2024-04-08 Buy 600.00 Weisblum Eric
2024-04-01 Buy 3408.00 Weisblum Eric
2023-12-21 Buy 500.00 Weisblum Eric
2023-12-18 Buy 200.00 Weisblum Eric
2023-12-07 Buy 600.00 Weisblum Eric
2023-11-30 Buy 1000.00 Weisblum Eric

SEC Filings


Form Type Description Pages Date
schedule Other 2 Nov 14, 2025
10-q Quarterly Reports 59 Nov 13, 2025
8-k 8K-related 13 Oct 24, 2025
8-k 8K-related 20 Oct 01, 2025
def Proxies and info statements 19 Sep 05, 2025
ars Annual reports 1 Sep 05, 2025
pre Proxies and info statements 19 Aug 25, 2025
10-q Quarterly Reports 57 Aug 13, 2025
8-k 8K-related 14 Aug 05, 2025
8-k 8K-related 13 Jul 29, 2025

Latest News


× Before browsing our site, please accept our cookies policy